American Association for Cancer Research Annual Meeting

Healio.com brings you the highlights from the American Association for Cancer Research Annual Meeting. Refer back to this page often to read the latest news from AACR, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News CoveragePerspective

Pembrolizumab induces durable responses in advanced Merkel cell carcinoma

April 19, 2016
NEW ORLEANS — First-line systemic therapy with the anti–PD-1 antibody pembrolizumab induced a high response rate in patients with…
Meeting News Coverage

Delays in radiation receipt for DCIS associated with increased ipsilateral tumor risk

April 19, 2016
NEW ORLEANS — Women with ductal carcinoma in situ who received radiation therapy more than 8 weeks after breast-conserving surgery faced a…
Meeting News CoverageVideo

VIDEO: Gene signature may guide adjuvant chemotherapy use in early-stage breast cancer

April 18, 2016
NEW ORLEANS — Lajos Pusztai, MD, DPhil, chief of breast medical oncology and co-director of the genetics, genomics and epigenetics program at…
Meeting News CoveragePerspective

MammaPrint helps predict benefit of adjuvant chemotherapy in early-stage breast cancer

April 18, 2016
NEW ORLEANS — A genomic test can help predict which patients with early-stage breast cancer will derive the most benefit from adjuvant…
Meeting News CoveragePerspective

Palbociclib exhibits antiproliferative activity in untreated early-stage breast cancer

April 18, 2016
NEW ORLEANS — Short-term preoperative therapy with palbociclib appeared to decrease Ki67 cellular proliferation in women with early-stage…
Meeting News CoveragePerspective

Neoadjuvant ado-trastuzumab emtansine, pertuzumab increases pathologic complete response in HER-2–positive breast cancer

April 18, 2016
NEW ORLEANS — Neoadjuvant treatment with ado-trastuzumab emtansine and pertuzumab appeared more beneficial than standard paclitaxel plus…
Meeting News CoverageVideo

VIDEO: More data needed to assess long-term benefits of neoadjuvant regimen for HER-2 positive breast cancer

April 18, 2016
NEW ORLEANS —Clifford A. Hudis, MD, FACP, CEO of ASCO, discusses the potential implications of the I-SPY 2 trial, results of which were…
Meeting News CoveragePerspective

Entrectinib shows promise for gene-mutated cancers

April 18, 2016
NEW ORLEANS — The oral anticancer drug entrectinib appeared safe and effective for the treatment of patients with several types of cancer who…
Meeting News Coverage

High concordance observed among PD-L1 expression diagnostic assays

April 18, 2016
NEW ORLEANS — Three commercially available diagnostic tests demonstrated similar efficacy when measuring PD-L1 protein expression in…
Meeting News CoveragePerspective

LOXO-101 shows promise for solid tumors with NTRK gene fusions

April 18, 2016
NEW ORLEANS — The investigational agent LOXO-101 demonstrated clinical activity in patients with solid tumors that had neurotrophic tyrosine…